中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
11期
33-34
,共2页
肾脏疾病%骨密度%变化
腎髒疾病%骨密度%變化
신장질병%골밀도%변화
Kidney disease%Bone density%Changes
目的：探讨肾脏疾病患者的骨密度变化情况。方法应用具有丰富经验和专业知识的临床检验人员进行研究组肾脏疾病患者和对照组健康人群骨密度检测工作,记录两组骨密度检测结果,分析不同肾小球滤过率对骨密度影响效果,通过统计分析获得结论。结果通过研究组肾脏疾病病人与对照组健康人群临床资料分析可知,研究组骨密度显著低于对照组；对比五组肾脏疾病患者骨密度可知,A组骨密度最高而E组骨密度最低,即肾功能越差则骨密度越低,对比结果差异有统计学意义(P<0.05)。结论肾脏疾病患者骨质疏松发生率将显著增加,临床医生应准确掌握肾脏疾病与骨密度相关性特征,对骨质疏松高危人群提供针对性的干预措施,有效缓解肾脏疾病患者骨密度下降速度,减少其骨质疏松发生率,保障患者生活质量及生命安全。
目的：探討腎髒疾病患者的骨密度變化情況。方法應用具有豐富經驗和專業知識的臨床檢驗人員進行研究組腎髒疾病患者和對照組健康人群骨密度檢測工作,記錄兩組骨密度檢測結果,分析不同腎小毬濾過率對骨密度影響效果,通過統計分析穫得結論。結果通過研究組腎髒疾病病人與對照組健康人群臨床資料分析可知,研究組骨密度顯著低于對照組；對比五組腎髒疾病患者骨密度可知,A組骨密度最高而E組骨密度最低,即腎功能越差則骨密度越低,對比結果差異有統計學意義(P<0.05)。結論腎髒疾病患者骨質疏鬆髮生率將顯著增加,臨床醫生應準確掌握腎髒疾病與骨密度相關性特徵,對骨質疏鬆高危人群提供針對性的榦預措施,有效緩解腎髒疾病患者骨密度下降速度,減少其骨質疏鬆髮生率,保障患者生活質量及生命安全。
목적：탐토신장질병환자적골밀도변화정황。방법응용구유봉부경험화전업지식적림상검험인원진행연구조신장질병환자화대조조건강인군골밀도검측공작,기록량조골밀도검측결과,분석불동신소구려과솔대골밀도영향효과,통과통계분석획득결론。결과통과연구조신장질병병인여대조조건강인군림상자료분석가지,연구조골밀도현저저우대조조；대비오조신장질병환자골밀도가지,A조골밀도최고이E조골밀도최저,즉신공능월차칙골밀도월저,대비결과차이유통계학의의(P<0.05)。결론신장질병환자골질소송발생솔장현저증가,림상의생응준학장악신장질병여골밀도상관성특정,대골질소송고위인군제공침대성적간예조시,유효완해신장질병환자골밀도하강속도,감소기골질소송발생솔,보장환자생활질량급생명안전。
Objective To investigate the changes of bone mineral density in patients with kidney disease.Methods Clinical Laboratory de signated personnel with expertise and experience in the completion of the study group and the control group in patients with healthy people working kidney disease, bone density testing, recording two bone density test results, analysis of different glomerular filtration rate effect on bone mineral density after giving statistical analysis concluded.Results The patients in the control group of healthy people with clinical data analysis shows that kidney disease study group, bone density study group was significantly lower than the control group; comparing five groups of bone mineral density in patients with known kidney disease, A group of the highest bone mineral density lowest group E,suggesting that bone mineral density was positively correlated with the glomerular filtration rate, renal function, the worse is that the lower bone density, comparing the results were statistically significant (P<0.05).Conclusion The incidence of osteoporosis in patients with kidney disease will increase significantly, clinicians should accurately grasp kidney disease associated with bone mineral density characteristics, providing targeted interventions for osteoporosis risk populations, effectively alleviate the rate of decline in bone mineral density in patients with kidney disease reduce their incidence of osteoporosis, quality of life and protect the lives and safety of patients.
